Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silybum marianum ointment for episiotomy wound healing and pain in primiparous women
IRCT20181110041603N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silybum marianum extract in episiotomy wound and episiotomy pain, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Episiotomy wound healing and Episiotomy pain intensity. Started Aug 2019; status: completed.
02
Drugs
silybum marianum extract
03
Conditions
episiotomy woundepisiotomy pain
Beyond the preview
Go deeper on IRCT20181110041603N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181110041603N1.